Entrada Therapeutics, Inc. (TRDA)
NASDAQ·Healthcare·Biotechnology
$6.45
-3.87%
Mkt Cap $274.07M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$13.50
Range $10.00 – $17.00
Implied Upside
+109.3%
Consensus $13.50 vs current $6.45
NASDAQ·Healthcare·Biotechnology
$6.45
-3.87%
Mkt Cap $274.07M
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$13.50
Range $10.00 – $17.00
+109.3%
Consensus $13.50 vs current $6.45